Ahead of The Center for Responsible Seafood’s Shrimp Summit, which is taking place in India in June, George Chamberlain reflects on the future of the industry and the recent allegations against some of the key players.
Genome edited fish are already being grown by commercial aquaculture operators in Japan, and the technology has huge potential to enhance the sector’s environmental stewardship, productivity and disease resistance.
A switch to farming giant river prawns is proving economically astute for a growing number of Bangladesh’s aquaculture operators, but the sector still has challenges to overcome.
Black tiger shrimp are experiencing something of a renaissance, especially in India and China, but experts such as Kontali analyst Ida Skancke, and leading Indian shrimp farmer Dr Manoj Sharma note that producers would be foolish to write off vannamei.
Crawfish farming is one of the most lucrative and sustainable forms of aquaculture in the US, but recent droughts in its southern heartlands are putting livelihoods at risk.
Access to quality data analysis has proved a huge help to a range of players across the salmon industry but, given the volatile and fragmentary nature of the shrimp sector, forecasting shrimp harvests has always been seen as being notoriously difficult.
Sharing practical tips for small-scale aquaculture operators, particularly those based in the tropics, to adapt and become more resilient to the changing climate and extreme weather events.
Uniting industry stakeholders from across Indonesia, Shrimp Outlook 2024 held discussions of the country’s shrimp production performance, as well as next steps for improving future productivity.
Investing in the right genetics tools and strategies can help shrimp farming companies succeed, despite the current economic challenges, according to The Center for Aquatic Technologies (CAT).
Chilean biotech startup Aquit is developing a preventative treatment against infections in fish that boosts natural immunity, improves survival rates and replaces the need for antibiotics, according to CEO Daniela Allerbon
